Cairn Investment Group’s Edwards Lifesciences EW Stock Holding History

Cairn Investment Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Hold	17,800	–	–	0.71%	37
2026 Q1	$1.43M	Hold	17,800	–	–	0.71%	35
2025 Q4	$1.52M	Hold	17,800	–	–	0.72%	35
2025 Q3	$1.38M	Hold	17,800	–	–	0.63%	38
2025 Q2	$1.39M	Buy	17,800 +2,500	+16%	+$186K	0.73%	37
2025 Q1	$1.11M	Sell	15,300 -900	-6%	-$64.4K	0.63%	38
2024 Q4	$1.2M	Hold	16,200	–	–	0.7%	39
2024 Q3	$1.07M	Hold	16,200	–	–	0.59%	42
2024 Q2	$1.5M	Hold	16,200	–	–	0.87%	35
2024 Q1	$1.55M	Hold	16,200	–	–	0.89%	36
2023 Q4	$1.24M	Hold	16,200	–	–	0.77%	38
2023 Q3	$1.12M	Hold	16,200	–	–	0.74%	38
2023 Q2	$1.53M	Hold	16,200	–	–	0.99%	29
2023 Q1	$1.34M	Sell	16,200 -335	-2%	-$26.3K	0.93%	33
2022 Q4	$1.23M	Buy	16,535 +335	+2%	+$25.8K	0.92%	37
2022 Q3	$1.34M	Sell	16,200 -1,400	-8%	-$135K	1.08%	30
2022 Q2	$1.67M	Hold	17,600	–	–	1.3%	29
2022 Q1	$2.85M	Hold	17,600	–	–	1.81%	20
2021 Q4	$2.28M	Hold	17,600	–	–	1.57%	22
2021 Q3	$1.99M	Hold	17,600	–	–	1.47%	24
2021 Q2	$1.82M	Sell	17,600 -100	-0.6%	-$9.43K	1.34%	26
2021 Q1	$1.48M	Hold	17,700	–	–	1.23%	31
2020 Q4	$1.61M	Hold	17,700	–	–	1.53%	26
2020 Q3	$1.41M	Hold	17,700	–	–	1.5%	26
2020 Q2	$1.22M	Sell	17,700 -1,200	-6%	-$85.3K	1.49%	31
2020 Q1	$1.19M	Hold	18,900	–	–	1.77%	24
2019 Q4	$1.47M	Buy	+18,900	New	+$1.48M	1.46%	31

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Cairn Investment Group's EW Position: Q2 2026 in Review

Cairn Investment Group held its Edwards Lifesciences (EW) position steady in Q2 2026 at 17,800 shares worth $1.61M. The position accounts for 0.71% of the portfolio, ranked #37.

Cairn Investment Group first reported a position in EW in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.85M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Cairn Investment Group held 17,800 shares of Edwards Lifesciences worth $1.61M as of Q2 2026.
Cairn Investment Group left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.71% of Cairn Investment Group's portfolio in Q2 2026, its #37 holding.
Cairn Investment Group first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
Cairn Investment Group's Edwards Lifesciences position peaked at $2.85M in Q1 2022.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cairn Investment Group's 13F filing for Q2 2026, filed 28 Jul 2026.